US 12371503
Methods of treatment using a leptin receptor agonist antibody
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 12371503 (Methods of treatment using a leptin receptor agonist antibody) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K38/2264